Pfizer on Tuesday announced they are moving into phase 2/3 trials in younger children at lower doses than with adults. Read More Share this:TwitterFacebookRedditLike this:Like Loading... Post navigation 2 face arraignment in road-rage shooting that killed boy, 6 I-Team: Illinois gun card delays and mix-ups
